Type 2 Diabetes Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are able to understand and agree to take part in the study on their own behalf
- People who have symptoms such as shortness of breath, difficulty breathing when lying flat, swollen ankles, or tiredness, or physical signs of heart failure, with a heart pumping function measured at 50% or above
- People who have been formally diagnosed with a specific type of heart failure (called HFpEF) based on a recognised scoring system used by European heart specialists, where a score of 5 or more confirms the diagnosis
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a known diagnosis of Type 1 Diabetes
- People who are pregnant, breastfeeding, or women of childbearing age who do not have a negative pregnancy test result
- People who have taken part in another clinical trial involving an experimental drug or device within the past 30 days
- People whose heart failure is currently in an unstable or worsening state, or who have fluid on the lungs
- People with a history of a specific type of abnormal heart rhythm involving a prolonged electrical signal in the heart (confirm with trial site)
- People with a certain type of partial blockage in the heart's electrical conduction system (second- or third-degree heart block)
- People with significantly abnormal liver test results or a history of liver disease
- People whose kidneys are functioning below a certain level, as measured by a standard kidney function test (eGFR below 30 mL/min/1.73m²)
- People who have any reason they cannot safely have an MRI scan, including those with implanted medical devices or pacemakers
- People with severe heart valve disease, or certain specific heart muscle or surrounding tissue conditions including restrictive cardiomyopathy, constrictive pericarditis, hypertrophic cardiomyopathy, myocarditis, or takotsubo cardiomyopathy
- People who have had a heart attack within the past 3 months
- People with a known diagnosis of a rare adrenal gland tumour called pheochromocytoma
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gerry P McCann, MD, University of Leicester
Phone: +44 (0)116 258 3038
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Ki
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.